Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03458806 · ClinicalTrials.gov registry record
Phono- and Electrocardiogram Assisted Detection of Valvular Disease
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 156
- Enrollment target
NCT03458806 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 156 participants.
The verdict
NCT03458806 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
Study Summary
The diagnosis of valvular heart disease (VHD), or its absence, invariably requires cardiac imaging. A familiar and inexpensive tool to assist in the diagnosis or exclusion of significant VHD could both expedite access to life-saving therapies and reduce the need for costly testing. The FDA-approved Eko Duo device consists of a digital stethoscope and a single-lead electrocardiogram (ECG), which wirelessly pairs with the Eko Mobile application to allow for simultaneous recording and visualization of phono- and electrocardiograms. These features uniquely situate this device to accumulate large sets of auscultatory data on patients both with and without VHD. In this study, the investigators seek to develop an automated system to identify VHD by phono- and electrocardiogram. Specifically, the investigators will attempt to develop machine learning algorithms to learn the phonocardiograms of patients with clinically important aortic stenosis (AS) or mitral regurgitation (MR), and then task the algorithms to identify subjects with clinically important VHD, as identified by a gold standard, from naïve phonocardiograms. The investigators anticipate that the study has the potential to revolutionize the diagnosis of VHD by providing a more accurate substitute to traditional auscultation.
Interventions
- DIAGNOSTIC_TEST AS Algorithm 1
- DIAGNOSTIC_TEST AS Algorithm 2
- DIAGNOSTIC_TEST MR Algorithm 1
- DIAGNOSTIC_TEST MR Algorithm 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-02-22 |
| Est. Completion | 2019-11-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03458806
The ClinicalTrials.gov registry entry for NCT03458806 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which AS Algorithm 1 is the first listed.
NCT03458806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03458806 about?
NCT03458806 is a clinical study titled "Phono- and Electrocardiogram Assisted Detection of Valvular Disease". The diagnosis of valvular heart disease (VHD), or its absence, invariably requires cardiac imaging. A familiar and inexpensive tool to assist in the diagnosis or exclusion of significant VHD could both expedite access to life-saving therapies and reduce the need for costly testing. The FDA-approved ...
What is the current status of trial NCT03458806?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2018-02-22. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT03458806?
The interventions under investigation include: AS Algorithm 1 (DIAGNOSTIC_TEST), AS Algorithm 2 (DIAGNOSTIC_TEST), MR Algorithm 1 (DIAGNOSTIC_TEST), MR Algorithm 2 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03458806?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.